2 results
Approved WMOPending
To assess the effect of betahistine on the severity / intensity of motion sickness
Approved WMOCompleted
To evaluate the safety and efficacy of subcutaneousbelimumab (GSK1550188) and intravenous rituximab coadministrationin subjects with primary Sjögren*s syndrome.